| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Stryker Corporation$325.7
-22.34 (-6.42%)
D 37Pipeline Score MedTech · Commercial
Market Cap
121.33 B
EPS
8.72
P/E Ratio
36.66 $
Value Trade
644.62 M
SEC Financials
Q1 2026Dilution Risk
Revenue
6.02 B
R&D Expenses
413.00 M
Operating CF
581.00 M
Total Assets
46.29 B
Total Liabilities
23.31 B
Equity
22.98 B
D/E Ratio
12,345
2.13 %
Week
-3.44 %
1 Month
-15.49 %
3 Month
-12.83 %
6 Month
23.84 %
5 Year
379,668.4 %
All Time
Cash Data
Cash Position
2.96 B
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 11, 2026
Overview
Volume
4.54 M
52 Week Range
281 - 404.87
% held by Insiders
5.98 %
% held by Institutions
81.05 %
Enterprise Value
133.60 B
Total Shares
383.32 M
Short %
2.02 %
Float Shares
347.67 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Stryker Corporation
374Total events
0Upcoming
92Tier-1 (high impact)
2012 – 2026Coverage
Event history 2
TBD
▲Quarterly UpdateCorporate
Subscribe to view catalyst details
TBD
▲Product LaunchPost-Market
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
2023-06-05 | Spy Agent Green Kit (indocyanine green) | PDUFA Date | PDUFA | Approved | – | – | – |
2023-06-05 | Spy Agent Green Kit (indocyanine green) | PDUFA Date | PDUFA | Approved | – | – | – |
2023-06-05 | Spy Agent Green Kit (indocyanine green) | PDUFA Date | PDUFA | Approved | – | – | – |
Drug Pipeline Intelligence
D37
Pipeline Score $454M
Pipeline ValueValuation Signal
3
Drugs Scored0.0x
rNPV / MCap Top 54%
Large Pharma (rank 421 of 913)
Percentile RankStryker Corporation faces pipeline headwinds (37/100), with $454M risk-adjusted pipeline value, led by Bone morphogenetic protein 7 in Osteoarthritis of the Knee (Phase 2).
Showing 1 of 1 assets
| Drug | Indication | Phase | NCT ID | PTRS | rNPV | Status | Enrollment | Velocity | Design | Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bone morphogenetic protein 7 Small molecule | Osteoarthritis of the Knee | Phase 2 | NCT01133613 | 17% | $306M | COMPLETED | 406 | - | - | Oct 1, 2011 | - | Feb 1, 2012 |
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SYK
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SYK Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SYK▼ -6.4%on this news
Stryker reports second quarter 2026 operating results
Stryker reported a strong second quarter for 2026, with net sales of $6.6 billion, reflecting a 9.4% increase. The company also saw a significant rise in earnings per share, which increased by 44.1% to $3.30. CEO Kevin A. Lobo highlighted the company's recovery from a cyber incident and expressed confidence in continued growth within the MedTech sector. The company has narrowed its full-year guidance, expecting organic net sales growth between 8.3% and 9.3%.
Read more →SYKStryker expands Mako robotics portfolio with full market release of Mako RPS
Stryker has launched the Mako RPS (Robotic Power System) for total knee replacement, expanding its Mako robotics portfolio. This new handheld technology integrates robotic execution with a familiar surgical experience, aiming to enhance accessibility for surgeons. The system is compatible with the clinically proven Triathlon Total Knee System and has received positive feedback during its limited release.
Read more →SYKStryker to announce second quarter 2026 financial results
Stryker will host a webcast on July 30, 2026, to discuss its second quarter financial results. The event will begin at 4:30 p.m. Eastern time, with a press release issued earlier at 4:05 p.m. This webcast will be accessible live and archived for later viewing on Stryker's website.
Read more →SYKStryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
Stryker has partnered with golfer Shane Lowry to highlight the caregiver's role in joint replacement. Lowry, who has firsthand experience as a caregiver for his father, aims to raise awareness about the challenges faced by caregivers. The campaign will focus on education and support for those dealing with joint pain and recovery.
Read more →SYKStryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
Stryker has launched the TPX HD power tool, aimed at enhancing performance in challenging orthopedic procedures. The tool is designed for total joint revisions and minimally invasive surgeries, featuring improved ergonomics and customizable control. Key attributes include increased torque and speed, making it a reliable choice for surgeons during demanding cases.
Read more →SYKStryker lanceert Pangea Plating System en voltooit de eerste case in Europa
Stryker has launched the Pangea Plating System and completed its first case in Europe. This new system aims to enhance surgical procedures, although specific details about its features and benefits were not disclosed in the article. The launch marks a significant step for Stryker in expanding its offerings in the European market.
Read more →SYKStryker bringt das Pangea-Plattensystem auf den Markt und schließt den ersten Eingriff in Europa ab
Stryker has introduced its Pangea plate system, marking a significant advancement in surgical technology. The company has successfully completed the first procedure using this system in Europe. This launch is expected to improve surgical outcomes and patient care in the region.
Read more →SYKBioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
Stryker's acquisition of Amplitude Vascular Systems for $835 million underscores the robustness of Michigan's medtech industry. This strategic move reflects a growing confidence among investors and stakeholders in the sector's future. The partnership is expected to enhance Stryker's portfolio and drive innovation in vascular solutions.
Read more →SYKStryker declares an $0.88 per share quarterly dividend
Stryker Corporation (NYSE:SYK) has announced a quarterly dividend of $0.88 per share, reflecting a 4.8% increase from the same period last year. The dividend will be payable on July 31, 2026, to all shareholders of record as of June 30, 2026. Stryker, known for its innovations in medical technologies, aims to enhance healthcare outcomes worldwide, impacting millions of patients annually. This announcement underlines Stryker's commitment to shareholder returns and its robust market position.
Read more →SYKStryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Stryker has completed the acquisition of Amplitude Vascular Systems, enhancing its peripheral vascular portfolio with next-generation intravascular lithotripsy technology. This acquisition is expected to improve treatment for complex peripheral arterial disease. Stryker aims to leverage AVS's innovative technology to better support physicians and patient outcomes.
Read more →SYK▼ -6.5%on this news
Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
Stryker (NYSE:SYK) will participate in the Bank of America Securities 2026 Global Healthcare Conference on May 13, 2026. Key executives, including President Spencer Stiles, will present at the event. A live webcast of the presentation will be available on Stryker's website, ensuring investor access.
Read more →SYKStryker reports first quarter 2026 operating results
Stryker reported a 2.6% increase in net sales for Q1 2026, totaling $6.0 billion. The company experienced a 14.2% rise in reported EPS, although adjusted EPS fell by 8.5%. CEO Kevin A. Lobo expressed confidence in meeting full-year guidance for organic sales growth, despite a contraction in adjusted operating income margin.
Read more →SYKStryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Stryker has signed a definitive agreement to acquire Amplitude Vascular Systems, enhancing its Peripheral Vascular portfolio with advanced intravascular lithotripsy technology. This acquisition aims to address significant clinical needs in treating calcified peripheral arterial disease. The technology promises improved treatment efficiency and is expected to grow in adoption among physicians.
Read more →SYKStryker to announce financial results for its first quarter of fiscal year 2026
Stryker Corporation will announce its financial results for the first quarter of fiscal year 2026 on April 30, 2026. A press release will be available at 4:05 p.m. ET, followed by a webcast at 4:30 p.m. ET to discuss the results. The company is known for its innovative medical technologies.
Read more →SYKStryker names Nick Mead Vice President, Investor Relations
Stryker has appointed Nick Mead as Vice President of Investor Relations, effective May 1, 2026. Mead, who has nearly 20 years of experience within the company, previously served as Vice President of Finance for the Medical division. His appointment is expected to strengthen Stryker's investor relations and support its strategic goals.
Read more →SYKStryker announces Annual Meeting of Shareholders
Stryker Corporation has announced its 2026 Annual Meeting of Shareholders, scheduled for May 6, 2026, at 12:00 p.m. Eastern Time. The meeting will be held virtually, with a webcast available for attendees. A recording will be accessible the following day, ensuring shareholders can review the meeting details.
Read more →SYKStryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
Stryker has launched Synchfix EVT, a next-generation flexible syndesmotic fixation device aimed at improving surgical efficiency and patient care. The device, which will be featured at the 2026 ACFAS Annual Meeting, simplifies deployment and is the first of its kind indicated for adolescent patients. Its innovative design has received the Red Dot Design Award, highlighting its advancements over previous models.
Read more →SYKStryker introduces Mako Handheld Robotics with the limited market release of Mako RPS
Stryker has announced the limited market release of its Mako RPS, a handheld robotic system designed for Total Knee procedures. This new platform integrates Stryker's robotics and power tool technologies, providing surgeons with a familiar experience while enhancing surgical precision. Mako RPS is compatible with Stryker's Triathlon Total Knee System and aims to improve patient outcomes in orthopaedic surgeries.
Read more →SYKSTRYKER REPORTS 2025 OPERATING RESULTS AND 2026 OUTLOOK Portage, Michigan
Stryker has announced significant growth in its operating results for the fourth quarter and full year of 2025, reporting an 11.4% increase in net sales. The company achieved a notable EPS increase of 56.0% in Q4 2025, alongside a healthy operating income margin improvement. Looking ahead to 2026, Stryker projects continued growth with expectations of organic sales growth between 8.0% and 9.5%. The CEO expressed confidence in the company's momentum and ability to sustain success in the MedTech sector.
Read more →SYKStryker to announce financial results for its fourth quarter and full year 2025
Stryker Corporation announced it will release its financial results for the fourth quarter and full year 2025 on January 29, 2026. A press release will be issued at 4:05 p.m. ET, followed by a webcast at 4:30 p.m. ET to discuss the results. The company emphasizes its commitment to improving healthcare outcomes.
Read more →SYKStryker names Spencer Stiles President and Chief Operating Officer
Stryker has appointed Spencer Stiles as President and Chief Operating Officer, effective January 1, 2026. Stiles, a veteran with 27 years at Stryker, will oversee global businesses and strategy. His leadership is expected to drive growth and innovation. Dylan Crotty will succeed him as Group President of Orthopaedics.
Read more →SYKStryker Way Portage, MI 49002 www.stryker.com
Stryker has appointed Spencer Stiles as President and Chief Operating Officer, effective January 1, 2026, to enhance growth and strategy execution. Stiles, a veteran with 27 years at Stryker, aims to leverage his experience to advance the company's goals. Dylan Crotty will take over Stiles' previous role as Group President of Orthopaedics, marking a continued emphasis on internal leadership growth. The company remains focused on improving healthcare outcomes through innovative products and services.
Read more →SYKStryker reports third quarter 2025 operating results
Stryker reported robust third quarter results for 2025, with net sales reaching $6.1 billion, a 10.3% increase. The company achieved double-digit growth in adjusted earnings per share and raised its full-year guidance. The performance was driven by strong demand across its MedSurg and Neurotechnology segments, contributing significantly to overall sales growth.
Read more →SYKStryker to announce financial results for its third quarter of fiscal year 2025
Stryker (NYSE:SYK) will announce its financial results for the third quarter of fiscal year 2025 on October 30, 2025. A press release will be issued at 4:05 p.m. ET, followed by a webcast at 4:30 p.m. ET to discuss the results. The company aims to provide insights into its performance for the quarter ending September 30, 2025.
Read more →SYKStryker to host investor day
Stryker will hold an Investor Day on November 13, 2025, at 2:30 p.m. ET in Mahwah, New Jersey. The event will feature a live audio webcast, which will also be available for replay on their official website. This initiative reflects Stryker's commitment to transparency and investor engagement.
Read more →SYKStryker to participate in the 2025 Wells Fargo Securities Healthcare Conference
Stryker will participate in the 2025 Wells Fargo Securities Healthcare Conference on September 4. Key executives, including Andy Pierce and Jason Beach, will engage in a Fireside Chat. A live audio webcast of the session will be available on Stryker's website, ensuring accessibility for stakeholders.
Read more →SYKStryker declares an $0.84 per share quarterly dividend
Stryker Corporation has announced a quarterly dividend of $0.84 per share, payable on October 31, 2025, to shareholders on record as of September 30, 2025. This marks a 5.0% increase from the previous year, while remaining unchanged from the last quarter. The announcement reflects Stryker's ongoing commitment to returning value to its shareholders.
Read more →SYKStryker reports second quarter 2025 operating results
Stryker reported strong operating results for Q2 2025, with net sales reaching $6.0 billion, reflecting an 11.1% increase. The company experienced significant growth in its MedSurg and Neurotechnology segments, while also raising its full-year guidance for organic net sales growth. Adjusted net earnings per diluted share rose to $3.13, marking an 11.4% increase compared to the previous year.
Read more →SYKStryker to announce financial results for its second quarter of fiscal year 2025
Stryker Corporation (NYSE: SYK) announced the scheduled release of its financial results for the second quarter of fiscal year 2025, set for July 31, 2025. A press release detailing the summary financial information will be issued at approximately 4:05 p.m. ET. Following this, a webcast will be held at 4:30 p.m. ET to discuss the results. Stryker emphasizes its role as a leader in medical technologies, impacting over 150 million patients globally.
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2025 OPERATING RESULTS Portage, Michigan
Stryker reported its first quarter 2025 operating results, highlighting a significant net sales increase of 11.9% to $5.9 billion, driven by robust demand in its MedSurg and Neurotechnology segments. Adjusted operating income improved by 100 basis points, showcasing enhanced profitability despite a drop in reported earnings per share. The company anticipates continued growth, raising its full-year organic net sales guidance to between 8.5% and 9.5%. However, challenges persist, notably a decrease in EPS and uncertainties related to tariffs and regulatory hurdles following its acquisition of Inari Medical, Inc.
Read more →SYKStryker to participate in the Bank of America Securities 2025 Global Healthcare Conference
Stryker will participate in the Bank of America Securities 2025 Global Healthcare Conference on May 13, 2025. The presentation will be led by CFO Preston Wells and VP Jason Beach at 1:40 p.m. PT. A live webcast will be available on Stryker's website, ensuring accessibility for investors and stakeholders.
Read more →SYKStryker to announce financial results for its first quarter of fiscal year 2025
Stryker Corporation has announced it will release its financial results for the first quarter of fiscal year 2025 on May 1, 2025. A press release will be available at 4:05 p.m. ET, following which the company will host a webcast to discuss these results at 4:30 p.m. ET. This announcement underscores Stryker's continued operation and engagement with investors, reflecting its commitment to healthcare improvement.
Read more →SYKStryker completes sale of U.S. spinal implants business
Stryker has completed the divestiture of its U.S. spinal implants business to Viscogliosi Brothers, LLC, which will operate as VB Spine, LLC. This move is intended to enhance Stryker's strategic focus on areas with greater innovation and growth potential. The company emphasized its ongoing commitment to the spine market through its remaining business segments and partnership with VB Spine. Future transfers of international markets to VB Spine are planned, pending regulatory approvals.
Read more →SYKStryker announces intention to nominate Manny Maceda to board of directors
Stryker has announced the nomination of Manny Maceda to its board of directors for election at the 2025 Annual Meeting of Shareholders on May 8, 2025. Maceda, who has extensive experience in leading corporate transformations, currently serves as Chairman of Bain & Company. His nomination is expected to bring valuable strategic insights and enhance Stryker's governance as the company continues to grow and focus on delivering long-term shareholder value.
Read more →SYKStryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
Stryker has completed its acquisition of Inari Medical, marking a significant expansion into the peripheral vascular market. The deal was finalized on February 19, 2025, following a successful cash tender offer. With this acquisition, Stryker integrates innovative thrombectomy solutions from Inari, enhancing its capabilities in treating venous thromboembolism. Inari's previous shares will cease trading, as it becomes a wholly owned subsidiary of Stryker.
Read more →SYKStryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day
Stryker Corporation (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on February 27, 2025. Management is scheduled to present at 12:15 p.m. Eastern Time at Citigroup Headquarters in New York. A webcast of the presentation will be available on Stryker's website, where it will also be archived for future access. Stryker emphasizes its dedication to advancing healthcare through innovative products and services in various medical fields.
Read more →SYKStryker announces Allan Golston will retire from Board of Directors
Stryker Corporation announced that Allan Golston, a member of its Board of Directors for 14 years, will not seek re-election at the upcoming 2025 Annual Meeting of Shareholders. Golston has made significant contributions, serving in various capacities, including as independent Lead Director. His extensive experience in healthcare and finance has aided Stryker in its global mission to improve healthcare outcomes. The company expresses gratitude for Golston's strategic guidance and leadership during his tenure.
Read more →SYKStryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
Stryker has announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, which will form a new entity called VB Spine. This transaction aims to enhance growth potential and foster innovation in spinal care, with the deal expected to close in the first half of 2025. Additionally, a binding offer for Stryker's spinal implants business in France is included, pending regulatory consultations. The new partnership intends to focus on surgeon-centric innovations and improving patient outcomes.
Read more →SYKStryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer Portage, Michigan
Stryker Corporation has announced the retirement of Glenn S. Boehnlein and the promotion of Preston Wells as the new Vice President and Chief Financial Officer. CEO Kevin A. Lobo praised Boehnlein for his leadership in Finance and IT, while expressing confidence in Wells's ability to drive the company's continued success. Wells brings extensive experience in finance and has held various leadership roles within Stryker, contributing to its strategic initiatives.
Read more →SYKSTRYKER REPORTS 2024 OPERATING RESULTS AND 2025 OUTLOOK Portage, Michigan
Stryker (NYSE: SYK) has reported a solid performance in Q4 and full year 2024, with net sales rising 10.7% to $6.4 billion. Adjusted EPS also saw a notable increase of 15.9% in the fourth quarter, marking a positive outlook for 2025 with expected organic sales growth of 8.0% to 9.0%. However, the company faced challenges with a significant decrease in reported EPS and goodwill impairments related to its Spine business. Despite these setbacks, Stryker continues to show strength in key market segments and anticipates closing its acquisition of Inari soon.
Read more →SYKStryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Stryker Corporation has initiated a tender offer to acquire all outstanding shares of Inari Medical, Inc. for $80.00 each in cash, as part of a previously announced merger agreement. The tender offer is set to expire on February 18, 2025, but is conditional on specific requirements, including majority shareholder participation. The transaction is expected to close by the end of the first quarter of 2025, pending regulatory approvals and other customary conditions. Inari’s Board of Directors has recommended that its stockholders accept the offer.
Read more →SYKStryker to announce financial results for its fourth quarter and full year 2024
Stryker Corporation (NYSE:SYK) is set to report its financial results for the fourth quarter and full year of 2024 on January 28, 2025. The announcement will be accompanied by a press release at 4:05 p.m. ET, followed by a webcast at 4:30 p.m. ET. The results will provide insight into the company's financial performance over the past year, highlighting its impact on healthcare through its various medical technologies.
Read more →SYKStryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker has announced a definitive agreement to acquire Inari Medical for $80 per share, totaling approximately $4.9 billion. The acquisition aims to strengthen Stryker's position in the growing peripheral vascular market, particularly in treating venous thromboembolism (VTE). This move is expected to enhance patient outcomes through Inari's innovative product line complementing Stryker's existing Neurovascular business. The transaction is subject to shareholder approval and customary closing conditions, with an anticipated completion by the first quarter of 2025.
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2024 OPERATING RESULTS Portage, Michigan
Stryker reported its operating results for the third quarter of 2024, highlighting a net sales increase of 11.9% to $5.5 billion. The company's adjusted operating income margin improved significantly to 24.7%, while adjusted EPS rose by 16.7%. Stryker's strong performance is attributed to steady demand for its products and effective pricing strategies. The company maintains an optimistic outlook for the remainder of the year, forecasting organic net sales growth between 9.5% and 10.0%. A conference call is scheduled for October 29, 2024, to discuss these results and provide further updates.
Read more →SYKStryker to announce its third quarter 2024 financial results
Stryker (NYSE: SYK) announced it will report its third quarter financial results for 2024 on October 29, 2024. A press release with summary financial information will be available at approximately 4:05pm ET on that date, followed by a webcast discussion at 4:30pm ET. The company is recognized for its innovative products and services in various medical sectors, contributing to improved healthcare outcomes globally.
Read more →SYKStryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions
Stryker has completed the acquisition of Vertos Medical Inc., which specializes in interventional pain management for chronic lower back pain. This acquisition aims to enhance Stryker's offerings in non-surgical solutions while expanding their influence in ambulatory surgery centers. The addition of Vertos Medical's technologies is expected to improve patient outcomes, particularly for those suffering from lumbar spinal stenosis.
Read more →SYKStryker completes acquisition of care.ai
Stryker has successfully completed its acquisition of care.ai, a firm specializing in AI-assisted virtual care workflows and smart room technology. This acquisition aims to enhance Stryker's healthcare IT offerings and connected medical devices portfolio. With this strategic move, Stryker plans to improve decision-making tools for caregivers and patients. The integration of care.ai's technology is intended to align with Stryker's mission of enhancing healthcare outcomes globally.
Read more →SYKStryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
Stryker has announced a definitive agreement to acquire Vertos Medical Inc., a company specializing in minimally invasive treatments for chronic lower back pain due to lumbar spinal stenosis. This acquisition aims to enhance Stryker's portfolio of interventional pain management solutions and expand its reach in ambulatory surgery centers. The mild® procedure, offered by Vertos Medical, is expected to provide pain relief with quicker recovery times for patients. The agreement is subject to customary closing conditions, and both companies will continue to operate separately until the transaction is finalized.
Read more →SYKStryker to participate in the 2024 Wells Fargo Healthcare Conference
Stryker Corporation (NYSE: SYK) is set to participate in the 2024 Wells Fargo Healthcare Conference on September 5, 2024, at Encore Boston Harbor. Key executives, including Spencer Stiles and Jason Beach, will represent the company during a scheduled session. A live webcast of the presentation will be available on Stryker's website, further emphasizing its commitment to transparency and investor relations. As a leader in medical technologies, Stryker aims to enhance healthcare outcomes for millions of patients globally.
Read more →SYKStryker announces definitive agreement to acquire care.ai, a leading virtual care and ambient intelligence solutions platform
Stryker (NYSE: SYK) has announced a definitive agreement to acquire care.ai, a company specializing in AI-assisted virtual care technologies. This acquisition aims to bolster Stryker's healthcare IT offerings and create a more connected medical device portfolio. The integration of care.ai's ambient intelligence solutions will enhance clinical workflows, addressing the ongoing challenges faced by healthcare providers such as staffing shortages and workplace safety. Both companies will operate independently until the transaction is finalized.
Read more →SYKStryker declares an $0.80 per share quarterly dividend
Stryker Corporation (NYSE:SYK) has announced a quarterly dividend of $0.80 per share, slated for payment on October 31, 2024, to shareholders recorded by September 30, 2024. This represents a 6.7% increase compared to the previous year, though it remains the same as the last quarter's dividend. The company is recognized as a leader in medical technologies, providing products and services that improve patient outcomes globally.
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2024 OPERATING RESULTS Portage, Michigan
Stryker Corporation reported strong second quarter results for 2024, with net sales rising 8.5% to $5.4 billion and an organic net sales growth of 9.0%. The adjusted EPS also showed robust growth, increasing by 10.6% to $2.81. While the company is optimistic about future sales growth, they noted potential unfavorable impacts from foreign currency exchange rates, which may affect their overall earnings guidance for the year.
Read more →SYKStryker to announce financial results for its second quarter of fiscal year 2024
Stryker announced that it will report financial results for the second quarter of fiscal year 2024 on July 30, 2024. The results will be discussed in a webcast at 4:30 PM ET the same day, following the issuance of a press release. These announcements indicate ongoing performance tracking and communication of company health.
Read more →SYKStryker declares a $0.80 per share quarterly dividend
Stryker's Board of Directors has declared a quarterly dividend of $0.80 per share, which will be payable on July 31, 2024, to shareholders recorded by June 28, 2024. This dividend reflects a 6.7% increase from the previous year, maintaining the same rate as the last quarter. As a leader in medical technologies, Stryker aims to enhance healthcare outcomes for millions globally.
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2024 OPERATING RESULTS Portage, Michigan
Stryker Corporation (NYSE: SYK) reported a 9.7% increase in net sales for Q1 2024, totaling $5.2 billion. The company's organic net sales rose by 10.0%, driven by strong unit volumes in its MedSurg and Neurotechnology sectors. Adjusted earnings per share saw a significant increase of 16.8% to $2.50. Despite favorable growth indicators, Stryker acknowledged potential risks from foreign exchange impacts and market volatility in their revenue projections for the full year.
Read more →SYKStryker to announce financial results for its first quarter of fiscal year 2024
Stryker Corporation will announce its financial results for the first quarter of fiscal year 2024 on April 30, 2024. The press release, which will be available around 4:05 PM ET, will include summary financial information for the quarter ending March 31, 2024. A webcast discussing these results will follow at 4:30 PM ET, accessible via the company's website. This announcement is part of Stryker's ongoing commitment to transparency and stakeholder engagement.
Read more →SYKStryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day
Stryker Corporation will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on February 29, 2024, in New York City. Key executives, including the CFO, will present at the event, which will also feature a webcast for those unable to attend. Stryker is recognized as a leader in medical technologies, offering innovative products that enhance patient outcomes globally.
Read more →SYKSTRYKER REPORTS 2023 OPERATING RESULTS AND 2024 OUTLOOK Portage, Michigan
Stryker Corporation (NYSE: SYK) has reported strong financial results for Q4 2023 and the full year, with net sales increasing by 11.8% to $5.8 billion. Organic sales growth was 11.4%, leading to a doubling of reported EPS. The outlook for 2024 appears positive, with expected sales growth between 7.5% and 9.0%, although the company also acknowledges potential headwinds from foreign currency fluctuations and pricing pressures.
Read more →SYKStryker announces 2023 sales surpassed $20 billion
Stryker Corporation has announced that it achieved a milestone by surpassing $20 billion in annual sales during December 2023. CEO Kevin Lobo expressed excitement about this achievement, highlighting the company's positive impact on customers and patients. Additional details regarding the company's financial results are expected to be disclosed during the upcoming Q4 and Full Year Earnings Call on January 30, 2024. Stryker continues to be a leader in medical technology, providing innovative products and services.
Read more →SYKStryker to announce financial results for its fourth quarter and full year 2023
Stryker (NYSE:SYK) has announced that it will release its financial results for the fourth quarter and full year 2023 on January 30, 2024. A press release summarizing these results will be available that day, followed by a webcast at 4:30 PM ET to discuss the financial performance. Stryker continues to focus on improving healthcare outcomes through innovative medical technologies, impacting millions of patients globally.
Read more →SYKStryker announces intention to nominate a new director, Rachel Ruggeri
Stryker Corporation announced its intention to nominate Rachel Ruggeri for election to its Board of Directors during the 2024 Annual Meeting of Shareholders, set for May 9, 2024. Ruggeri, who has over 25 years of experience in global finance, currently serves as the Chief Financial Officer at Starbucks. Her extensive expertise in financial strategies and retail operations is anticipated to contribute positively to Stryker's leadership. The company's CEO expressed enthusiasm about the potential addition of Ruggeri to the Board, highlighting her valuable insights from a prominent global consumer company.
Read more →SYKStryker announces Dr. Srikant Datar will retire from Board of Directors
Stryker (NYSE:SYK) has announced that Dr. Srikant Datar will retire from its Board of Directors and will not stand for re-election at the 2024 Annual Meeting of Shareholders. Dr. Datar has served on the board for 15 years, contributing to the company's strategic growth ambitions. Stryker's leadership expresses gratitude for his valuable insights and guidance in enhancing healthcare outcomes. The upcoming meeting is scheduled for May 9, 2024.
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2023 OPERATING RESULTS Kalamazoo, Michigan
Stryker reported its third quarter 2023 operating results, highlighting a 9.6% increase in net sales to $4.9 billion. A rise in adjusted EPS was noted, increasing by 16.0% to $2.46, indicating positive trends in operational performance. Despite a decrease in reported EPS and net earnings, the company maintained strong organic sales growth and improved margins. Stryker anticipates organic net sales growth to range between 10.0% and 10.5% for the full year.
Read more →SYKStryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
Stryker Corporation will participate in the 6th Annual Evercore ISI HealthCONx Conference on November 29, 2023, in Miami, Florida. Key representatives from the company, including the CFO, will present during the event and engage with investors. An archived webcast of the presentation will also be accessible on the company’s website. This participation underscores Stryker's commitment to transparency and strengthening relationships with stakeholders.
Read more →SYKStryker to announce financial results for its third quarter of fiscal year 2023
Stryker Corporation announced its upcoming financial results for the third quarter of fiscal year 2023, set to be released on November 2, 2023, at 4:05 PM ET. A webcast will follow at 4:30 PM ET to discuss these results, accessible through Stryker's website. This announcement comes after the close of the third quarter on September 30, 2023, highlighting Stryker's ongoing commitment to improving patient outcomes through innovative medical technologies.
Read more →SYKStryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
Stryker (NYSE:SYK) is set to participate in the 2023 Wells Fargo Securities Healthcare Conference on September 7, 2023. The presentation will be led by Glenn Boehnlein, CFO, and Jason Beach, VP of Investor Relations, at 3:00 p.m. Eastern Time. The event will also include a simultaneous webcast, which will be archived on Stryker's Investor Relations page for further viewing. Stryker is recognized as a leading medical technology company focused on enhancing patient outcomes globally.
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2023 OPERATING RESULTS Kalamazoo, Michigan
Stryker Corporation reported strong financial results for the second quarter of 2023, with net sales increasing by 11.2% to $5.0 billion. The company also saw adjusted earnings per share rise by 12.9%, highlighting solid profitability within its operations. Key segments, including MedSurg and Neurotechnology, contributed significantly to organic sales growth. Additionally, Stryker raised its full-year guidance for organic net sales growth, reflecting positive demand trends.
Read more →SYKStryker declares a $0.75 per share quarterly dividend
Stryker Corporation has announced a quarterly dividend of $0.75 per share, payable on October 31, 2023, to shareholders recorded by September 29, 2023. This dividend reflects a 7.9% increase compared to the same period last year and remains consistent with the previous quarter. Known for its contributions to medical technology, Stryker is committed to enhancing healthcare through its various innovative products and services.
Read more →SYKStryker to announce financial results for its second quarter of fiscal year 2023
Stryker announced that it will report its financial results for the second quarter of fiscal year 2023 on August 3, 2023. The report will be accompanied by a press release and a webcast discussion of the results. This financial performance update reflects the company's ongoing activities in the medical technology sector.
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2023 OPERATING RESULTS Kalamazoo, Michigan
Stryker reported its first quarter operating results for 2023, revealing a net sales increase of 11.8% to $4.8 billion and a significant 83.3% rise in reported EPS to $1.54. The company highlighted strong organic sales growth particularly in MedSurg and Neurotechnology and Orthopaedics and Spine segments. However, the adjusted operating income margin did contract, and Stryker anticipates a potential negative impact on sales and EPS from foreign exchange fluctuations. The firm also projected organic net sales growth of 8.0% to 9.0% for the full year.
Read more →SYKStryker to announce financial results for its first quarter of fiscal year 2023
Kalamazoo, Michigan, March 30, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Rel
Read more →SYKSTRYKER REPORTS 2022 OPERATING RESULTS AND 2023 OUTLOOK Kalamazoo, Michigan
Stryker (NYSE: SYK) reported its 2022 operating results, highlighting a 10.7% increase in net sales for Q4 2022, totaling $5.2 billion. Despite a decrease in reported EPS by 15% to $1.47, adjusted EPS rose by 10.7% to $3.00. The company anticipates continued sales growth in 2023, projected organic net sales growth of 7.0% to 8.5%, but faces challenges such as foreign exchange impacts and managed pricing pressures.
Read more →SYKStryker to host conference call on January 31, 2023
Kalamazoo, Michigan, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an oper
Read more →SYKStryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, Investor Relations will r
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS THIRD QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan - October 31, 2022 - Stryker (NYSE SYK) reported operating results for the third quarter of 2022 Third Quarter Results Reported net sales increased 7.7% to $4.5 billion Organic net sales increased 9.9%
Read more →SYKStryker to host conference call on October 31, 2022
Kalamazoo, Michigan, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an ope
Read more →SYKStryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor
Read more →SYKStryker declares a $0.695 per share quarterly dividend
Kalamazoo Michigan, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable October 31, 2022 to shareholders of record at the close of business on September 30, 2022, representing an
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS SECOND QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan - July 26, 2022 - Stryker (NYSE SYK) reported operating results for the second quarter of 2022 Second Quarter Results Reported net sales increased 4.6% to $4.5 billion Organic net sales increased 6.1%
Read more →SYKStryker Corp and Zimmer Biomet Holdings Inc Among Leading Companies in the Bone Cement Market | Globaldata Plc
LONDON, July 07, 2022 (GLOBE NEWSWIRE) -- The “Bone Cement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report offered by GlobalData Plc discusses in detail the impact of
Read more →SYKStryker to host conference call on July 26, 2022
Kalamazoo, Michigan, June 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational
Read more →SYKDocument 2825 Airview Boulevard Kalamazoo, MI 49002 Press release Date
EX-99.1 2 ex9912022boardchangespress.htm EX-99.1 Document 2825 Airview Boulevard Kalamazoo, MI 49002 Press release Date May 5, 2022 Stryker announces board changes following Annual Meeting of Shareholders Kalamazoo, Michigan - May 5, 2022 - Stryker (NYSE SYK) announced that on Ma
Read more →SYKStryker announces new Investor Relations leader
Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Jason Beach will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective July 1, 2022. Preston Wells, Vice President, Invest
Read more →SYKStryker announces board changes following Annual Meeting of Shareholders
Kalamazoo, May 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary
Read more →SYKStryker to participate in the Bank of America Securities 2022 Health Care Conference
Kalamazoo, May 02, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2022 Health Care Conference on Wednesday, May 11, 2022. Andy Pierce, Group President, MedSurg and Neurotechnology and Preston Wells, Vice President, Investor Relatio
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS FIRST QUARTER 2022 OPERATING RESULTS Kalamazoo, Michigan - April 28, 2022 - Stryker (NYSE SYK) reported operating results for the first quarter of 2022 First Quarter Results Reported net sales increased 8.1% to $4.3 billion Organic net sales increased 9.2% Re
Read more →SYKStryker to host conference call on April 28, 2022
Kalamazoo, Michigan, March 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operatio
Read more →SYKStryker completes acquisition of Vocera Communications
Kalamazoo, MI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication. “This acquisition provides signif
Read more →SYKStryker to participate in Cowen 42nd Annual Health Care Conference
Kalamazoo, Michigan, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation sch
Read more →SYKSTRYKER REPORTS 2021 OPERATING RESULTS AND 2022 OUTLOOK Kalamazoo, Michigan
STRYKER REPORTS 2021 OPERATING RESULTS AND 2022 OUTLOOK Kalamazoo, Michigan - January 27, 2022 - Stryker (NYSE SYK) reported operating results for the fourth quarter and full year of 2021 Fourth Quarter Results Reported net sales increased 10.3% from 2020 and 13.8% from 2019 t
Read more →SYKStryker commences tender offer for all outstanding shares of common stock of Vocera Communications
Kalamazoo, Michigan, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) today announced that it is commencing, through a wholly owned subsidiary, Voice Merger Sub Corp., a cash tender offer to purchase all outstanding shares of common stock of Vocera Communications, Inc. (NYSE:
Read more →SYKSTRYKER CORPORATION (Unaudited - Millions of Dollars) SUPPLEMENTAL PRODUCT SALES INFORMATION 2021 2020 2019 Three Months Three Months Full Year Three Months Full Year March 31 June 30 September 30 December 31 December 31
STRYKER CORPORATION (Unaudited - Millions of Dollars) SUPPLEMENTAL PRODUCT SALES INFORMATION 2021 2020 2019 Three Months Three Months Full Year Three Months Full Year March 31 June 30 September 30 December 31 December 31 December 31 December 31 MedSurg and Neurotech
Read more →SYKStryker announces definitive agreement to acquire Vocera Communications
Kalamazoo, Michigan, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per share, or a total equity value o
Read more →SYKStryker to host conference call on January 27, 2022
Kalamazoo, Michigan, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an oper
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS THIRD QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan - October 28, 2021 - Stryker (NYSE SYK) reported operating results for the third quarter of 2021 Third Quarter Results Reported net sales increased 11.3% from 2020 and 16.0% from 2019 to $4.2 billion Org
Read more →SYKStryker to host analyst meeting
Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be avai
Read more →SYKStryker to host conference call on October 28, 2021
Kalamazoo, Michigan, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an op
Read more →SYKStryker to participate in Morgan Stanley’s 19th Annual Global Healthcare Conference
Kalamazoo, Michigan, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Morgan Stanley’s 19th Annual Global Healthcare Conference on Monday, September 13, 2021. Kevin Lobo, Chair and Chief Executive Officer, will represent the Company in a virtual presentat
Read more →SYKStryker President and COO Timothy J. Scannell to retire
Kalamazoo, Michigan, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that after an outstanding thirty-one-year career at Stryker, Timothy J. Scannell, President and Chief Operating Officer has notified the company of his intent to retire on March 31, 2023. Ef
Read more →SYKStryker declares a $0.63 per share quarterly dividend
Kalamazoo, Michigan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable October 29, 2021 to shareholders of record at the close of business on September 30, 2021, representing an
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS SECOND QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan - July 27, 2021 - Stryker (NYSE SYK) reported operating results for the second quarter of 2021 Second Quarter Results Reported net sales increased 55.4% from 2020 and 17.6% from 2019 to $4.3 billion Org
Read more →SYKStryker to host conference call on July 27, 2021
Kalamazoo, Michigan, June 24, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2021 and provide an operational
Read more →SYKStryker-Munley Group launches new Diversity, Equity and Inclusion practice
SAN ANTONIO, May 11, 2021 (GLOBE NEWSWIRE) -- Stryker-Munley Group (SMG), a Charleston, S.C.-based integrated public relations and marketing communication agency, today announced the launch of its new Diversity, Equity and Inclusion (DEI) practice. SMG named Mae Escobar national
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS FIRST QUARTER 2021 OPERATING RESULTS Kalamazoo, Michigan - April 27, 2021 - Stryker (NYSE SYK) reported operating results for the first quarter of 2021 The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governmen
Read more →SYKStryker to participate in the Bank of America Securities 2021 Virtual Health Care Conference
Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Spencer Stiles, Group President, Orthopaedics & Spine, Robert Cohen, President, Digital, Ro
Read more →SYKStryker to host conference call on April 27, 2021
Kalamazoo, Michigan, March 29, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2021 and provide an operation
Read more →SYKStryker to participate in the 41st Annual Cowen Health Care Conference
Kalamazoo, Michigan, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021. Preston Wells, Vice President, Investor Relations and Andy Pierce, Group President, MedSurg & Neurotechnology, wi
Read more →SYKSTRYKER REPORTS 2020 OPERATING RESULTS AND 2021 OUTLOOK Kalamazoo, Michigan
STRYKER REPORTS 2020 OPERATING RESULTS AND 2021 OUTLOOK Kalamazoo, Michigan - January 27, 2021 - Stryker (NYSE SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook The response to the COVID-19 pandemic has included measures to slow the s
Read more →SYKStryker acquires OrthoSensor
Kalamazoo, Michigan, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeleta
Read more →SYKStryker to host conference call on January 27, 2021
Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2020 and provide an ope
Read more →SYKStryker-Munley Group Selects MAPRagency for Expansion to Colorado’s Front Range
BOULDER, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Stryker-Munley Group (SMG), a Charleston, S.C.-based integrated public relations and marketing communication agency, has selected MAPRagency to establish SMG offices in Boulder, Fort Collins and Denver as part of a national expansion pla
Read more →SYKStryker announces pricing of $600 million senior notes offering
Kalamazoo, Michigan, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) (the “Company”) announced today that it has priced an offering of $600 million aggregate principal amount of its 0.600% Notes due 2023 (the “Notes”). Unless previously redeemed pursuant to their terms, the
Read more →SYKStryker to participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference
Kalamazoo, Michigan, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Thursday, December 3, 2020. Preston Wells, Vice President, Investor Relations and Spencer Stiles, Group President, Orthopaed
Read more →SYKStryker completes acquisition of Wright Medical
Kalamazoo, Michigan, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics. “This acquisit
Read more →SYKStryker announces intention to complete acquisition of Wright Medical
Kalamazoo, Michigan, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuating the mergers described in the tender offer statement on Schedule TO filed by Stryker B
Read more →SYKStryker elects Giovanni Caforio to Board of Directors
Kalamazoo, Michigan, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Giovanni Caforio, M.D., Chairman and Chief Executive Officer of Bristol Myers Squibb, has been elected to its Board of Directors, effective December 1, 2020. “Giovanni adds extensive e
Read more →SYKStryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical
Kalamazoo, Michigan, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for the previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) by S
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS THIRD QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan - October 29, 2020 - Stryker (NYSE SYK) reported operating results for the third quarter of 2020 The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus ta
Read more →SYKStryker extends cash tender offer for all outstanding shares of Wright Medical
Kalamazoo, Michigan, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wri
Read more →SYKStryker to host conference call on October 29, 2020
Kalamazoo, Mchigan, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 29, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2020 and provide an ope
Read more →SYKStryker to participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference
Kalamazoo, Michigan, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a pr
Read more →SYKStryker declares a $0.575 per share quarterly dividend
Kalamazoo, Michigan, July 30, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable October 30, 2020 to shareholders of record at the close of business on September 30, 2020, representing an
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS SECOND QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan - July 30, 2020 - Stryker (NYSE:SYK) reported operating results for the second quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus ta
Read more →SYKStryker to host conference call on July 30, 2020
Kalamazoo, Michigan, June 25, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2020 and provide an operational
Read more →SYKStryker announces pricing of $2.3 billion senior notes offering
Kalamazoo, Michigan, May 26, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) (the “Company”) announced today that it has priced the following senior notes: (i) $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025 (the “2025 Notes”), (ii) $1 billion aggregate
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS FIRST QUARTER 2020 OPERATING RESULTS Kalamazoo, Michigan - April 30, 2020 - Stryker (NYSE:SYK) reported operating results for the first quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus tak
Read more →SYKStryker to host conference call on April 30, 2020
Kalamazoo, Michigan, April 09, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2020 and provide an operatio
Read more →SYKStryker announces nomination of new Director, Lisa Skeete Tatum
Kalamazoo, Michigan, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020. Ms. Skeete Tatum is
Read more →SYKAirview Boulevard Kalamazoo, MI 49002 Press release Stryker announces nomination of new Director, Lisa Skeete Tatum Kalamazoo, Michigan
EX-99.1 2 sykex991pressrelease02.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 2825 Airview Boulevard Kalamazoo, MI 49002 Press release Stryker announces nomination of new Director, Lisa Skeete Tatum Kalamazoo, Michigan - February 25, 2020 - Stryker (NYSE:SYK) announced that Lisa Skeete
Read more →SYKStryker to participate in Cowen 40th Annual Health Care Conference
Kalamazoo, Michigan, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy & Investo
Read more →SYKStryker named to the 100 Best Companies to Work For list for 10th consecutive year
Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual surve
Read more →SYKSTRYKER REPORTS 2019 RESULTS AND 2020 OUTLOOK Kalamazoo, Michigan
STRYKER REPORTS 2019 RESULTS AND 2020 OUTLOOK Kalamazoo, Michigan - January 28, 2020 - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2019 and 2020 outlook: Fourth Quarter Highlights Fourth Quarter Net Sales Growth Overview Reported Fo
Read more →SYKStryker reports 2019 results and 2020 outlook
Kalamazoo, MI, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2019 and 2020 outlook: Fourth Quarter Highlights Reported net sales increased 8.8% to $4.1 billion Organic net sales increased 8.0% Reported
Read more →SYKStryker to host conference call on January 28, 2020
Kalamazoo, Michigan, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – January 6, 2020 – Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 28, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ende
Read more →SYKStryker increases dividend 11%, declaring a $0.575 per share quarterly dividend
Kalamazoo, Michigan, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on January 31, 2020 to shareholders of record at the close of business on December 31, 2019, representing
Read more →SYKStryker announces pricing of €2.4 billion senior notes offering
Kalamazoo, Michigan, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has priced the following senior notes: (i) €850 million aggregate principal amount of the Company’s 0.25% Notes due 2024 (the “2024 Notes”), (ii) €800 million aggregate principal amo
Read more →SYKStryker announces definitive agreement to acquire Wright Medical
Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximatel
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS THIRD QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan - October 29, 2019 - Stryker (NYSE:SYK) reported operating results for the third quarter of 2019: Third Quarter Highlights Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Co
Read more →SYKStryker completes acquisition of Mobius Imaging and Cardan Robotics
Kalamazoo, Michigan, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today it has completed the acquisition of Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics). “Mobius Imaging and Card
Read more →SYKStryker to host conference call on October 29, 2019
Kalamazoo, Michigan, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, October 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2019 and provide an ope
Read more →SYKStryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics
Kalamazoo, Michigan, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics), in an all cash transaction
Read more →SYKStryker to participate in Morgan Stanley 17th Annual Global Healthcare Conference
Kalamazoo, Michigan, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) ) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represen
Read more →SYKStryker announces commercial structure realignment
Kalamazoo, Michigan, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today an adjustment to its commercial organizational structure. Spencer S. Stiles will serve as Group President of Orthopaedics and Spine and will oversee Stryker’s Joint Replacement, Trauma & Ext
Read more →SYKStryker declares a $0.52 per share quarterly dividend
Kalamazoo, Michigan, July 31, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record at the close of business on September 30, 2019, representing
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS SECOND QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan - July 25, 2019 - Stryker (NYSE:SYK) reported operating results for the second quarter of 2019: Second Quarter Highlights Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange C
Read more →SYKStryker to host conference call on July 25, 2019
Kalamazoo, Michigan, June 24, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 25, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2019 and provide an operational
Read more →SYKStryker to participate in Bank of America Merrill Lynch 2019 Health Care Conference
Kalamazoo, Michigan, May 01, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President and Chief Financi
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan
STRYKER REPORTS FIRST QUARTER 2019 OPERATING RESULTS Kalamazoo, Michigan - April 23, 2019 - Stryker (NYSE:SYK) reported operating results for the first quarter of 2019: First Quarter Highlights First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Cons
Read more →SYKStryker announces new Vice President, Chief Legal Officer
Kalamazoo, Michigan, March 27, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Rob Fletcher will be joining the company as Vice President, Chief Legal Officer effective April 22, 2019. Mike Hutchinson will be transitioning from his current role to serve as Adviso
Read more →SYKStryker to host conference call on April 23, 2019
Kalamazoo, Michigan, March 21, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 23, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2019 and provide an operation
Read more →SYKStryker acquires OrthoSpace, Ltd.
Kalamazoo, Michigan, March 14, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $1
Read more →SYKStryker acquires Arrinex
Kalamazoo, Michigan, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the tre
Read more →SYKStryker to participate in 8th Annual Leerink Partners Global Healthcare Conference
Kalamazoo, Michigan, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 at the Lotte New York Palace in New York, New York. Katherine Owen, Vice President, Strategy
Read more →SYKStryker reports 2018 results and 2019 outlook
Kalamazoo, Michigan, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2018 and 2019 outlook: Fourth Quarter Highlights • Reported net sales increased 9.4% to $3.8 billion Organic net sales increased 8
Read more →SYKSTRYKER REPORTS 2018 RESULTS AND 2019 OUTLOOK Kalamazoo, Michigan
STRYKER REPORTS 2018 RESULTS AND 2019 OUTLOOK Kalamazoo, Michigan - January 29, 2019 - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2018 and 2019 outlook: Fourth Quarter Highlights Reported net sales increased 9.4% to $3.8 billion Fou
Read more →SYKStryker to host conference call on January 29, 2019
Kalamazoo, Michigan, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2018 and provide an opera
Read more →SYKStryker increases dividend 11%, declaring a $0.52 per share quarterly dividend
Kalamazoo, Michigan, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on January 31, 2019 to shareholders of record at the c
Read more →SYKStryker announces pricing of €2.25 billion senior notes offering
Kalamazoo, Michigan, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “2023 Notes”), (ii) €750 million aggregate principal amount of
Read more →SYKStryker to participate in Evercore ISI HealthCONx Conference
Kalamazoo, Michigan, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts. Katherine Owen, Vice President, Strategy and Investor Relatio
Read more →SYKStryker completes acquisition of K2M
Kalamazoo, Michigan, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc., a global leader of complex spine and minimally invasive solutions. "K2M's broad product portfolio and robust pipeline complem
Read more →SYKStryker completes acquisition of K2M Kalamazoo, Michigan
EX-99.1 2 sykex99111092018.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Stryker completes acquisition of K2M Kalamazoo, Michigan - November 9, 2018 - Stryker (NYSE: SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc., a global leader of complex spine and
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2018 OPERATING RESULTS Reported net sales increased 7.9% to $3.2 billion Organic net sales increased 7.9% Reported operating income margin of 17.8% Adjusted operating income margin (1) expan
STRYKER REPORTS THIRD QUARTER 2018 OPERATING RESULTS Kalamazoo, Michigan - October 25, 2018 - Stryker (NYSE:SYK) reported operating results for the third quarter of 2018: Third Quarter Highlights 2018 Net Sales Growth Overview Reported Excluding ASC 606 Adoption (2) Foreig
Read more →SYKStryker completes acquisition of Invuity, Inc.
Kalamazoo, Michigan - October 23, 2018 - Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc. Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide vari
Read more →SYKStryker acquires HyperBranch Medical Technology, Inc.
Kalamazoo, Michigan - October 1, 2018 - Stryker (NYSE:SYK) announced today the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all cash transaction. HyperBranch is dedicated to developing medical devi
Read more →SYKStryker to host conference call on October 25, 2018
Kalamazoo, Michigan - September 20, 2018 - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 25, 2018 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2018 and provide an operational upd
Read more →SYKStryker announces definitive agreement to acquire Invuity, Inc.
Kalamazoo, Michigan - September 11, 2018 - Stryker (NYSE: SYK) announced today a definitive agreement to acquire all the issued and outstanding shares of common stock of Invuity, Inc. (NASDAQ: IVTY) for $7.40 per share, or a total equity value of approximately $190 million. Invui
Read more →SYKStryker to participate in Morgan Stanley 16th Annual Global Healthcare Conference
Kalamazoo, Michigan - September 4, 2018 - Stryker (NYSE:SYK) will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018 at the Grand Hyatt New York in New York City. Katherine Owen, Vice President, Strategy and Investor Relat
Read more →SYKStryker announces definitive agreement to acquire K2M Kalamazoo, Michigan
Stryker announces definitive agreement to acquire K2M Kalamazoo, Michigan - August 30, 2018 - Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of K2M Group Holdings, Inc. (NASDAQ: KTWO) for $27.
Read more →SYKStryker to participate in 2018 Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan - August 22, 2018 - Stryker (NYSE:SYK) will participate in the 2018 Wells Fargo Securities Healthcare Conference on Thursday, September 6, 2018 at the Westin Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy and Investor Relation
Read more →SYKStryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - August 1, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on October 31, 2018 to shareholders of record at the close of business on September 28, 2018, representing an i
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2018 OPERATING RESULTS Reported net sales increased 10.3% to $3.3 billion Organic net sales increased 7.9% Reported operating income margin of 20.2% Adjusted operating income margin (1) exp
STRYKER REPORTS SECOND QUARTER 2018 OPERATING RESULTS Kalamazoo, Michigan - July 24, 2018 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2018: Second Quarter Highlights 2018 Net Sales Growth Overview Reported Excluding ASC 606 Adoption
Read more →SYKStryker announces organizational changes
Kalamazoo, Michigan - July 10, 2018 - Stryker Corporation (NYSE:SYK) announced today that David K. Floyd, Group President, Orthopaedics has notified the Company of his intent to retire on June 30, 2019. Until this date, Mr. Floyd will serve as Group President and Advisor to the C
Read more →SYKStryker announces definitive agreement to acquire SafeAir AG
Kalamazoo, Michigan - June 25, 2018 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire SafeAir AG, a Swiss medical device company dedicated to the design, development and manufacture of innovative surgical smoke evacuation solutions. The company's
Read more →SYKStryker to host conference call on July 24, 2018
Kalamazoo, Michigan - June 19, 2018 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, July 24, 2018 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2018 and provide an operational updat
Read more →SYKStryker to participate in Bank of America Merrill Lynch 2018 Health Care Conference
Kalamazoo, Michigan - May 4, 2018 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2018 Health Care Conference on Tuesday, May 15, 2018 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President and Chief Financial Off
Read more →SYKStryker to participate in Deutsche Bank's 43rd Annual Health Care Conference
Kalamazoo, Michigan - May 1, 2018 - Stryker Corporation (NYSE:SYK) will participate in Deutsche Bank's 43rd Annual Health Care Conference on Tuesday, May 8, 2018 at the Intercontinental Hotel Boston. Katherine Owen, Vice President, Strategy and Investor Relations, will represent
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2018 OPERATING RESULTS Reported net sales increased 9.7% to $3.2 billion Organic net sales increased 7.0% despite one less selling day Reported operating income margin of 18.2% Adjusted oper
STRYKER REPORTS FIRST QUARTER 2018 OPERATING RESULTS Kalamazoo, Michigan - April 26, 2018 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2018: First Quarter Highlights 2018 Net Sales Growth Overview Reported Excluding ASC 606 Adoption
Read more →SYKStryker announces organizational changes: Lonny J. Carpenter to retire
Kalamazoo, Michigan - April 3, 2018 - Stryker Corporation (NYSE:SYK) announced today that after 30 years of distinguished service, Lonny Carpenter, Group President, Global Quality and Business Operations has notified the Company of his intent to retire on March 31, 2019. Mr. Car
Read more →SYKStryker to host conference call on April 26, 2018
Kalamazoo, Michigan - March 22, 2018 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, April 26, 2018 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2018 and provide an operational u
Read more →SYKStryker completes acquisition of Entellus Medical
Kalamazoo, Michigan - February 28, 2018 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Entellus Medical. Entellus is a high-growth global medical technology company focused on delivering superior patient and physician e
Read more →SYKStryker Corporation announces pricing of $600 million senior notes offering
Kalamazoo, Michigan - February 26, 2018 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $600 million of senior unsecured notes due 2028 (the "Notes"). The Notes will bear interest at 3.650% per year and, unless previously redeemed, will ma
Read more →SYKStryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for eighth consecutive year
Kalamazoo, Michigan - February 15, 2018 - Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2018 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States. The list recognizes companies tha
Read more →SYKStryker crosses the 95% thresholds in VEXIM and announces its intention to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM
Kalamazoo, Michigan - February 14, 2018 - Stryker Corporation (NYSE:SYK) announced that it has crossed the 95% thresholds in VEXIM and intends to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM, in accordance with French tender o
Read more →SYKSTRYKER REPORTS 2017 RESULTS AND 2018 OUTLOOK Kalamazoo, Michigan
STRYKER REPORTS 2017 RESULTS AND 2018 OUTLOOK Kalamazoo, Michigan - January 30, 2018 - Stryker Corporation (NYSE:SYK) reported 2017 operating results for the fourth quarter and full year and 2018 outlook: Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% con
Read more →SYKStryker reports 2017 results and 2018 outlook
Kalamazoo, Michigan - January 30, 2018 - Stryker Corporation (NYSE:SYK) reported 2017 operating results for the fourth quarter and full year and 2018 outlook: Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % co
Read more →SYKSTRYKER PROVIDES 2017 PRELIMINARY NET SALES RESULTS Kalamazoo, Michigan
STRYKER PROVIDES 2017 PRELIMINARY NET SALES RESULTS Kalamazoo, Michigan - January 9, 2018 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2017 were: Preliminary Fourth Quarter Highlights Net sales grew 10.0% to $3.
Read more →SYKStryker announces nomination of two new Directors, Sheri S. McCoy and Rajeev Suri Kalamazoo, Michigan
EX-99.1 2 ex991syk8k1518.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Stryker announces nomination of two new Directors, Sheri S. McCoy and Rajeev Suri Kalamazoo, Michigan - January 8, 2018 - Stryker Corporation (NYSE:SYK) announced that Sherilyn (Sheri) S. McCoy and Rajeev Suri have be
Read more →SYKStryker to participate in 36th Annual J.P. Morgan Healthcare Conference
Kalamazoo, Michigan - January 2, 2018 - Stryker Corporation (NYSE:SYK) will participate in the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at the Westin St. Francis hotel in San Francisco. Kevin A. Lobo, Chairman and Chief Executive Officer, will
Read more →SYKStryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors Kalamazoo, Michigan
EX-99.1 2 ex991syk8k121117.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors Kalamazoo, Michigan - December 12, 2017 - Stryker Corporation (NYSE:SYK) announced today that after 44 years of distinguished service, Mr.
Read more →SYKStryker announces the success of the simplified tender offer for outstanding shares of VEXIM
Kalamazoo, Michigan - December 11, 2017 - Stryker Corporation (NYSE:SYK) announced that the simplified public tender offer for the shares and BSAAR warrants of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France, has closed. VEXIM, headq
Read more →SYKStryker announces definitive agreement to acquire Entellus
Kalamazoo, Michigan - December 7, 2017 - Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share, or an equity value of approximately $662 million. Entellus is a high-growth global medica
Read more →SYKStryker increases dividend 11%, declaring a $0.47 per share quarterly dividend
Kalamazoo, Michigan - December 6, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record at the close of business on December 29, 2017, representing an
Read more →SYKStryker reports third quarter 2017 results
Kalamazoo, Michigan - October 26, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2017: Third Quarter Highlights Net sales grew 6.1% to $3.0 billion (5.8% constant currency) Orthopaedics 5.1 % or 4.8 % constant currency MedSurg 6.7 % o
Read more →SYKSTRYKER REPORTS THIRD QUARTER 2017 RESULTS Kalamazoo, Michigan
STRYKER REPORTS THIRD QUARTER 2017 RESULTS Kalamazoo, Michigan - October 26, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2017: Third Quarter Highlights Net sales grew 6.1% to $3.0 billion (5.8% constant currency) Orthopaedics 5.1
Read more →SYKStryker to acquire VEXIM
Kalamazoo, Michigan - October 24, 2017 - Stryker Corporation (NYSE:SYK) announced that it has acquired control of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France. VEXIM, headquartered in Balma, France, specializes in the development
Read more →SYKStryker to host conference call on October 26, 2017
Kalamazoo, Michigan - September 21, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 26, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2017 and provide an ope
Read more →SYKStryker to participate in Morgan Stanley 15th Annual Global Healthcare Conference
Kalamazoo, Michigan - September 6, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Morgan Stanley 15th Annual Global Healthcare Conference on Tuesday, September 12, 2017 at the Grand Hyatt Hotel in New York, New York. Kevin Lobo, Chairman and Chief Executive Office
Read more →SYKStryker completes acquisition of NOVADAQ Technologies Inc.
Kalamazoo, Michigan - September 1, 2017 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of NOVADAQ Technologies Inc. NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualizatio
Read more →SYKStryker provides an update regarding Sage warning letter and revised financial guidance
Kalamazoo, Michigan - August 23, 2017 - Stryker Corporation (NYSE: SYK) announced today that the company has informed the U.S. Food and Drug Administration (FDA) of a voluntary product recall involving specific lots of Oral Care products sold through the company's Sage Products b
Read more →SYKStryker announces election of new Director, Mary K. Brainerd
Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced the addition of a new member to its Board of Directors with the election of Mary K. Brainerd as a Director, effective August 1, 2017. Ms. Brainerd was most recently President and Chief Executive Offi
Read more →SYKStryker declares a $0.425 per share quarterly dividend
Kalamazoo, Michigan - August 2, 2017 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on October 31, 2017 to shareholders of record at the close of business on September 29, 2017, representing an
Read more →SYKSTRYKER REPORTS SECOND QUARTER 2017 RESULTS Kalamazoo, Michigan
STRYKER REPORTS SECOND QUARTER 2017 RESULTS Kalamazoo, Michigan - July 27, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2017: Second Quarter Highlights Net sales grew 6.1% to $3.0 billion (6.9% constant currency) Orthopaedics 5.5
Read more →SYKStryker reports second quarter 2017 results
Kalamazoo, Michigan - July 27, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2017: Second Quarter Highlights Net sales grew 6.1% to $3.0 billion (6.9% constant currency) Orthopaedics 5.5 % or 6.5% constant currency MedSurg 6.2 % or
Read more →SYKStryker to host conference call on July 27, 2017
Kalamazoo, Michigan - June 22, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 27, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2017 and provide an operational upda
Read more →SYKStryker announces definitive agreement to acquire NOVADAQ Technologies Inc.
Kalamazoo, Michigan - June 19, 2017- Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ) for US$11.75 per share, or US$701 million with a net purchase price of US$654 million, reflecting net cash of app
Read more →SYKStryker to participate in Goldman Sachs 38th Annual Global Healthcare Conference
Kalamazoo, Michigan - May 31, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, June 14, 2017 at the Terranea Resort in Rancho Palos Verdes, California. Glenn Boehnlein, Vice President and Chief Fin
Read more →SYKStryker Orthopaedics 2016 Settlement Program reaches milestone
95% of Registered Eligible U.S. Patients Enrolled in Program Kalamazoo, Michigan - May 8, 2017- Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"), a subsidiary of Stryker Corporation, has informed the courts in the Ne
Read more →SYKStryker to participate in Bank of America Merrill Lynch 2017 Health Care Conference
Kalamazoo, Michigan - May 4, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2017 Health Care Conference on Wednesday, May 17, 2017 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President and Chief Financial O
Read more →SYKSTRYKER REPORTS FIRST QUARTER 2017 RESULTS Kalamazoo, Michigan
STRYKER REPORTS FIRST QUARTER 2017 RESULTS Kalamazoo, Michigan - April 25, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2017: First Quarter Highlights Net sales grew 18.4% to $2.96 billion (18.8% constant currency) MedSurg 36.2 % o
Read more →SYKStryker reports first quarter 2017 results
Kalamazoo, Michigan - April 25, 2017 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2017: First Quarter Highlights Net sales grew 18.4% to $2.96 billion (18.8% constant currency) MedSurg 36.2 % or 36.6% constant currency Orthopaedics 7.4 %
Read more →SYKStryker to host conference call on April 25, 2017
Kalamazoo, Michigan - March 27, 2017 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, April 25, 2017 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2017 and provide an operational up
Read more →SYKStryker enabling surgeons to have a more predictable surgical experience with launch of Mako robotic-arm assisted total knee application
The first and only robotic technology that can be used across the joint replacement service line to perform total knee, total hip and partial knee replacements now available Kalamazoo, Michigan - March 14, 2017 - Stryker Corporation (NYSE:SYK) announced the commercial launch of
Read more →SYKStryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for seventh consecutive year
Kalamazoo, Michigan - March 9, 2017 - Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2017 100 Best Companies to Work For in its 20th annual survey of top-rated workplaces in the United States. The list recognizes companies that have excepti
Read more →SYKStryker to participate in Cowen & Company 37th Annual Health Care Conference
Kalamazoo, Michigan - February 21, 2017 - Stryker Corporation (NYSE:SYK) will participate in the Cowen & Company 37th Annual Health Care Conference on Monday, March 6, 2017 at the Boston Marriott Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy and
Read more →SYKStryker reports 2016 results and 2017 outlook
Kalamazoo, Michigan - January 24, 2017 - Stryker Corporation (NYSE:SYK) reported 2016 operating results for the fourth quarter and full year and 2017 outlook: Fourth Quarter Highlights Net sales grew 16.2% to $3.2 billion (16.8% constant currency) Orthopaedics 5.3 % or 5.7% co
Read more →SYKStryker provides 2016 preliminary net sales results
Kalamazoo, Michigan - January 10, 2017 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2016 were: Preliminary Fourth Quarter Highlights Net sales grew 16.3% to $3.2 billion (16.8% constant currency) Orthopaedics 5.
Read more →SYKStryker to participate in 35th Annual J.P. Morgan Healthcare Conference
Kalamazoo, Michigan - January 3, 2017 - Stryker Corporation (NYSE:SYK) will participate in the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis hotel in San Francisco. Kevin A. Lobo, Chairman and Chief Executive Officer, will
Read more →SYKStryker Orthopaedics to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Kalamazoo, Michigan - December 19, 2016 - Stryker Corporation (NYSE:SYK) announced that Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG
Read more →SYKStryker increases 2017 annual dividend by 12% and declares a $0.425 per share quarterly dividend
Kalamazoo, Michigan - December 7, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.425 per share payable on January 31, 2017 to shareholders of record at the close of business on December 30, 2016, representing an
Read more →SYKStryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India
Kalamazoo, Michigan - November 14, 2016 - Stryker Corporation (NYSE:SYK), one of the world's leading medical technology companies, announced today a multi-year collaboration with Indo UK Institute of Health's (IUIH) Medicity Program to serve as a preferred partner in the orthopae
Read more →SYKStryker to participate in Stifel 2016 Healthcare Conference
Kalamazoo, Michigan - November 8, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Stifel 2016 Healthcare Conference on Wednesday, November 16, 2016 at the Lotte New York Palace Hotel. Katherine Owen, Vice President, Strategy and Investor Relations, will represent th
Read more →SYKStryker reports third quarter 2016 results
Kalamazoo, Michigan - October 27, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2016: Third Quarter Highlights Net sales grew 17.1% to $2.8 billion (16.7% constant currency) Orthopaedics 5.6 % or 5.3% constant currency MedSurg 33.0 %
Read more →SYKStryker to host conference call on October 27, 2016
Kalamazoo, Michigan - September 26, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 27, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2016 and provide an ope
Read more →SYKStryker to participate in Morgan Stanley Global Healthcare Conference
Kalamazoo, Michigan - September 7, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company
Read more →SYKStryker to participate in 11th Annual Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan - August 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the 11th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2016 at the The Westin Boston Waterfront in Boston, Massachusetts. Katherine Owen, Vice President, St
Read more →SYKStryker declares a $0.38 per share quarterly dividend
Kalamazoo, Michigan - July 27, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on October 31, 2016 to shareholders of record at the close of business on September 30, 2016, representing an in
Read more →SYKStryker reports second quarter 2016 results
Kalamazoo, Michigan - July 21, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2016: Second Quarter Highlights Net sales grew 16.8% to $2.8 billion (17.0% constant currency) Orthopaedics 4.6 % or 4.8% constant currency MedSurg 33.8 %
Read more →SYKStryker to host conference call on July 21, 2016
Kalamazoo, Michigan - June 16, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 21, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2016 and provide an operational upda
Read more →SYKStryker to participate in Goldman Sachs 37th Annual Global Healthcare Conference
Kalamazoo, Michigan - May 31, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at the Terranea Resort in Rancho Palos Verdes, California. Kevin Lobo, Chairman and Chief Executive Officer
Read more →SYKStryker to participate in UBS 2016 Global Healthcare Conference
Kalamazoo, Michigan - May 17, 2016 - Stryker Corporation (NYSE:SYK) will participate in the UBS 2016 Global Healthcare Conference on Tuesday, May 24, 2016 at the Grand Hyatt New York in New York, New York. Katherine Owen, Vice President, Strategy and Investor Relations, will rep
Read more →SYKStryker to participate in Bank of America Merrill Lynch 2016 Health Care Conference
Kalamazoo, Michigan - May 2, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at the Encore at Wynn Hotel in Las Vegas, Nevada. Glenn Boehnlein, Vice President, Chief Financial Office
Read more →SYKStryker acquires Stanmore Implants Worldwide Limited
Kalamazoo, Michigan - April 29, 2016 - Stryker Corporation (NYSE:SYK) announced today it has acquired Stanmore Implants Worldwide Limited from SIW Holdings Limited in an all cash transaction for £35.6 million. Stanmore Implants is an innovative orthopaedic business focused on se
Read more →SYKStryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
Kalamazoo, Michigan - April 21, 2016 - Stryker Corporation (NYSE: SYK) announced today it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company) in an all cash transaction. The portfolio
Read more →SYKStryker reports first quarter 2016 results
Kalamazoo, Michigan - April 20, 2016 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2016: First Quarter Highlights Net sales grew 4.9% to $2.5 billion (6.1% constant currency) Orthopaedics 3.3 % or 4.6% constant currency MedSurg 3.4 % or 4
Read more →SYKStryker completes acquisition of Physio-Control International, Inc.
Kalamazoo, Michigan - April 5, 2016 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Physio-Control International, Inc. (Physio-Control). Physio-Control develops, manufactures and markets monitors/defibrillators, automat
Read more →SYKStryker completes the acquisition of Synergetics USA, Inc.'s Neuro Portfolio
Kalamazoo, Michigan - April 1, 2016 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Synergetics USA, Inc.'s Neuro Portfolio. The portfolio includes the Malis generator, Spetzler Malis disposable forceps, and Stryker's exi
Read more →SYKStryker completes acquisition of Sage Products, LLC
Kalamazoo, Michigan - April 1, 2016 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Sage Products, LLC ("Sage"). Sage's products include solutions for oral care, skin preparation and protection, patient cleaning and hyg
Read more →SYKStryker to host conference call on April 20, 2016
Kalamazoo, Michigan - March 18, 2016 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, April 20, 2016 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2016 and provide an operational
Read more →SYKStryker Corporation named one of Fortune magazine's "100 Best Companies to Work For" for sixth consecutive year
Kalamazoo, Michigan - March 3, 2016 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the Fortune's 2016 100 Best Companies to Work For in its 19th annual survey of top-rated workplaces in the United States. The list recognizes companies that have
Read more →SYKStryker Corporation Announces Pricing of $3.5 Billion Senior Notes Offering
Kalamazoo, Michigan - March 3, 2016 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $3.5 billion of senior unsecured notes consisting of the following tranches (the "Notes"): $750 million of 3-year fixed rate notes due March 8, 2019 bearin
Read more →SYKStryker to Participate in Cowen & Company 36th Annual Health Care Conference
Kalamazoo, Michigan - February 29, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Cowen & Company 36th Annual Health Care Conference on Monday, March 7, 2016 at the Boston Marriott Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy and
Read more →SYKStryker to Participate in Canaccord Genuity 2016 Musculoskeletal Conference
Kalamazoo, Michigan - February 22, 2016 - Stryker Corporation (NYSE:SYK) will participate in the Canaccord Genuity 2016 Musculoskeletal Conference on Tuesday, March 1, 2016 at the Hyatt Regency in Orlando, Florida. William J. Huffnagle, President, Reconstructive Division, will re
Read more →SYKStryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
Kalamazoo, Michigan - February 16, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire 100% of the stock of Physio-Control International, Inc. ("Physio-Control") in an all cash transaction for $1.28 billion. Physio-Control, which is a portfol
Read more →SYKStryker Announces Definitive Agreement to Acquire Synergetics USA, Inc.'s Neuro Portfolio
Kalamazoo, Michigan - February 10, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire all of the assets associated with Synergetics USA, Inc.'s neuro portfolio in an all cash transaction. The portfolio includes the Malis generator, Spetzler M
Read more →SYKStryker Declares a $0.38 per Share Quarterly Dividend
Kalamazoo, Michigan - February 10, 2016 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.38 per share payable on April 29, 2016, to shareholders of record at the close of business on March 31, 2016, representing an inc
Read more →SYKStryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
Kalamazoo, Michigan - February 1, 2016 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire Sage Products, LLC ("Sage") from Madison Dearborn Partners in an all cash transaction for $2.775 billion. The transaction includes an anticipated future tax
Read more →SYKStryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
Kalamazoo, Michigan - January 26, 2016 - Stryker Corporation (NYSE: SYK) announced today that William R. Jellison will retire from his role as Vice President, Chief Financial Officer. Bill's decision follows an impressive 36 year career, the last three of which have been with Str
Read more →SYKStryker Reports 2015 Results and 2016 Outlook
Kalamazoo, Michigan - January 26, 2016 - Stryker Corporation (NYSE:SYK) reported 2015 operating results for the fourth quarter and full year and 2016 outlook: Fourth Quarter Highlights Net sales grew 3.7% to $2.7 billion (7.0% constant currency) Orthopaedics 3.3 % or 7.1% cons
Read more →SYKStryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
Kalamazoo, Michigan - January 12, 2016 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2015 were: Preliminary Fourth Quarter Highlights Net sales grew 3.7% to $2.7 billion (7.0% constant currency) Orthopaedics 3.3
Read more →SYKStryker to Participate in 34th Annual J.P. Morgan Healthcare Conference
Kalamazoo, Michigan - January 4, 2016 - Stryker Corporation (NYSE:SYK) will participate in the 34th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2016 at the Westin St. Francis Hotel in San Francisco, California. Kevin A. Lobo, Chairman and Chief Executive Of
Read more →SYKStryker Corporation Announces Pricing of $750 Million Senior Notes Offering
Kalamazoo, Michigan - October 26, 2015 - Stryker Corporation (NYSE:SYK) announced today that it has priced an offering to sell $750 million of senior unsecured notes due 2025 (the "Notes"). The Notes will bear interest at 3.375% per year and, unless previously redeemed, will matu
Read more →SYKStryker Reports Third Quarter 2015 Results
Kalamazoo, Michigan - October 22, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2015: Third Quarter Highlights Net sales grew 1.3% to $2.4 billion (5.9% constant currency) Orthopaedics 0.3 % or 5.8% constant currency MedSurg 0.6 % or
Read more →SYKStryker to Host Conference Call on October 22, 2015
Kalamazoo, Michigan - September 18, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 22, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2015 and provide an ope
Read more →SYKStryker to Participate in 2015 Morgan Stanley Global Healthcare Conference
Kalamazoo, Michigan - September 8, 2015 - Stryker Corporation (NYSE:SYK) will participate in the 2015 Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015 at the Grand Hyatt New York. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Comp
Read more →SYKStryker Completes Acquisition of Muka Metal, A.S.
Kalamazoo, Michigan - September 1, 2015 - Stryker Corporation (NYSE: SYK) announced today the completion of its previously announced acquisition of Muka Metal, A.S. ("Muka"). Muka is a privately held business headquartered in Kayseri, Turkey that sells hospital beds, stretchers a
Read more →SYKStryker to Participate in 2015 Wells Fargo Securities Healthcare Conference
Kalamazoo, Michigan - August 28, 2015 - Stryker Corporation (NYSE:SYK) will participate in the 2015 Wells Fargo Securities Healthcare Conference on Wednesday, September 9, 2015 at the Hyatt Regency Boston. Katherine Owen, Vice President, Strategy and Investor Relations, will repr
Read more →SYKSTRYKER RECEIVES FDA CLEARANCE FOR MAKO TOTAL KNEE APPLICATION
Kalamazoo, Michigan - August 6, 2015 - Stryker Orthopaedics, a division of Stryker Corporation (NYSE:SYK), today announced that its 510(k) submission for the Mako total knee application has received market clearance by the U.S. Food and Drug Administration. This clearance expand
Read more →SYKStryker to Participate in Canaccord Genuity 35th Annual Growth Conference
Kalamazoo, Michigan - August 6, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Canaccord Genuity 35th Annual Growth Conference on Wednesday, August 12, 2015 at the InterContinental Boston. Katherine Owen, Vice President, Strategy and Investor Relations, will repres
Read more →SYKStryker Declares a $0.345 per Share Quarterly Dividend
Kalamazoo, Michigan - July 29, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.345 per share payable on October 30, 2015, to shareholders of record at the close of business on September 30, 2015, representing an
Read more →SYKStryker Reports Second Quarter 2015 Results
Kalamazoo, Michigan - July 23, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2015: Second Quarter Highlights Raises full year organic sales growth guidance to 5.5% to 6.5% Raises full year adjusted diluted net earnings per share gui
Read more →SYKStryker Announces Definitive Agreement to Acquire Muka Metal, A.S.
Kalamazoo, Michigan - July 20, 2015 - Stryker Corporation (NYSE: SYK) announced today a definitive agreement to acquire Muka Metal, A.S. ("Muka") in an all cash transaction. Muka, headquartered in Kayseri, Turkey, sells hospital beds, stretchers and related patient room furniture
Read more →SYKStryker to Host Conference Call on July 23, 2015
Kalamazoo, Michigan - June 22, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 23, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2015 and provide an operational upda
Read more →SYKStryker Orthopaedics Settlement Program Reaches Milestone - - 95% of Registered Eligible U.S. Patients Enrolled in Program
Kalamazoo, Michigan - June 12, 2015 - Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"), a subsidiary of Stryker Corporation (NYSE:SYK), has informed the courts in the New Jersey Multicounty and Federal Multidistrict litigations that 95% of registered eligible pat
Read more →SYKStryker and Black Diamond Lead Transformation in U.S. Integrated Operating Room Market
VANCOUVER, BC, June 11, 2015 (GLOBE NEWSWIRE) -- via PRWEB - June 11, 2015 - Vancouver, BC - The new iData Research (http://www.idataresearch.com) report series entitled U.S. Market for Video, High-Tech and Integrated Operating Theatre Equipment reveals that the U.S. integrated o
Read more →SYKStryker to Participate in Jefferies 2015 Healthcare Conference
Kalamazoo, Michigan - May 15, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Jefferies 2015 Healthcare Conference on Tuesday, June 2, 2015 at the Grand Hyatt Hotel in New York, New York. Adam Bisnett, Director, Investor Relations and Strategy, will represent the Co
Read more →SYKStryker to Participate in UBS Global Healthcare Conference
Kalamazoo, Michigan - May 6, 2015 - Stryker Corporation (NYSE:SYK) will participate in the UBS Global Healthcare Conference on Tuesday, May 19, 2015 at the Sheraton New York Times Square Hotel in New York, New York. David Floyd, Group President, Orthopaedics, will represent the C
Read more →SYKStryker to Participate in Bank of America Merrill Lynch 2015 Health Care Conference
Kalamazoo, Michigan - May 5, 2015 - Stryker Corporation (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015 at the Encore at the Wynn Hotel in Las Vegas, Nevada. Bill Jellison, Vice President, Chief Financial Offic
Read more →SYKStryker Reports First Quarter 2015 Results
Kalamazoo, Michigan - April 21, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2015: First Quarter Highlights Updates full year organic sales growth guidance to 5.0% to 6.0% Updates full year adjusted diluted net earnings per share gu
Read more →SYKStryker Announces Annual Meeting of Shareholders
Kalamazoo, Michigan - March 19, 2015 - Stryker Corporation (NYSE:SYK) announced that its 2015 Annual Meeting of Shareholders is scheduled as follows: April 29, 2015 - 2:00 p.m. Eastern Time Radisson Plaza Hotel & Suites at The Kalamazoo Center Information about the webcast, wh
Read more →SYKStryker to Host Conference Call on April 21, 2015
Kalamazoo, Michigan - March 18, 2015 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, April 21, 2015 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2015 and provide an operational up
Read more →SYKStryker to Present at Investor Conference
Kalamazoo, Michigan - March 11, 2015 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conference: March 24, 2015 - 1:00 p.m. Pacific Time 2015 Canaccord Genuity Musculoskeletal Conference A simultaneous webcast of the Company'
Read more →SYKStryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For " For 5th Consecutive Year
Fifth consecutive year Stryker has been named to this list Ranked 19 out of 100 Kalamazoo, Michigan - March 5, 2015 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the 2015 FORTUNE 100 Best Companies to Work For® in its 18th annual survey of to
Read more →SYKStryker Announces New $2 Billion Share Repurchase Authorization
Kalamazoo, Michigan - March 3, 2015- Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has authorized a new $2 billion share repurchase program. The program is in addition to $583 million of existing authorization remaining under the Company's current sha
Read more →SYKStryker Declares a 13% Increase in Quarterly Dividend
Kalamazoo, Michigan - February 11, 2015 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has increased its dividend 13% by declaring a quarterly dividend of $0.345 per share payable on April 30, 2015, to shareholders of record at the close of business on Mar
Read more →SYKStryker Reports 2014 Results and 2015 Outlook
Kalamazoo, Michigan - January 27, 2015 - Stryker Corporation (NYSE:SYK) reported operating results for the fourth quarter and full year of 2014: Fourth Quarter Highlights Net sales grew 6.1% to $2.6 billion (8.6% constant currency) Orthopaedics(1)
Read more →SYKStryker Provides 2014 Preliminary Results and Updates 2015 Foreign Exchange Outlook
Kalamazoo, Michigan - January 13, 2015 - Stryker Corporation (NYSE:SYK) announced today that preliminary results for the fourth quarter and full year 2014 were: Preliminary Fourth Quarter Highlights · Net sales growth of 6.1% to $2.6 billion or 8.6% constant currency
Read more →SYKStryker Acquires the Assets of CHG Hospital Beds, Inc.
Kalamazoo, Michigan - January 5, 2015 - Stryker Corporation (NYSE: SYK) announced today the asset acquisition of privately-held CHG Hospital Beds, Inc. ("CHG") in an all cash transaction. CHG, headquartered in London, Ontario, Canada, sells innovative hospital beds that serve mar
Read more →SYKStryker Resolves Government Investigation of OtisMed Matter
Kalamazoo, Michigan - December 8, 2014 -Stryker Corporation (NYSE:SYK) announced today that it has entered into a settlement with the U.S. Department of Justice (DOJ) in connection with the DOJ's civil and criminal investigations into the sales and marketing of the OtisKnee prior
Read more →SYKStryker Orthopaedics Announces Settlement Agreement To Compensate Eligible U.S. Patients Who Had Surgery To Replace Their Rejuvenate Modular-Neck and/or ABG II Modular-Neck Hip Stems
Kalamazoo, Michigan - November 3, 2014 - Howmedica Osteonics Corp. (referred to as "Stryker Orthopaedics"), a subsidiary of Stryker Corporation, and Court-appointed committees of attorneys representing Rejuvenate Modular-Neck and ABG II Modular-Neck plaintiffs in New Jersey Multi
Read more →SYKStryker Reports Third Quarter 2014 Results and 2014 Outlook
Kalamazoo, Michigan - October 16, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2014: Net sales grew 11.1% to $2.4 billion - Reconstructive 8.5% - MedSurg
Read more →SYKStryker to Host Conference Call on October 16, 2014
Kalamazoo, Michigan - September 8, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 16, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2014 and provide an oper
Read more →SYKStryker Completes Acquisition of North American Assets of Small Bone Innovations, Inc.
Kalamazoo, Michigan - August 1, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its acquisition of substantially all of the North American assets of Small Bone Innovations, Inc. ("SBi"). A separate closing will be held later this year, following receipt of
Read more →SYKStryker Announces Appointment of Kevin A. Lobo as Chairman of the Board of Directors
Kalamazoo, Michigan - July 22, 2014 - Stryker Corporation (NYSE:SYK) announced that Kevin A. Lobo, President and Chief Executive Officer, has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 22, 2014. William U. Parfet, Stryker's N
Read more →SYKStryker Declares a $0.305 Quarterly Dividend
Kalamazoo, Michigan - July 21, 2014- Stryker Corporation (NYSE:SYK) announced that its Board of Directors has maintained a dividend consistent with that of the prior quarter, by declaring a quarterly dividend of $0.305 per share payable on October 31, 2014, to shareholders of rec
Read more →SYKStryker to Host Analyst Meeting
Kalamazoo, Michigan - July 18, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host an Analyst Meeting on Wednesday, September 17, 2014, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. Kevin Lobo, President and Chief Executive Officer, will host the meeting with p
Read more →SYKStryker Reports Second Quarter 2014 Results and 2014 Outlook
Kalamazoo, Michigan - July 17, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2014: Net sales grew 6.8% to $2.4 billion · Reconstructive 6.5% · MedSurg
Read more →SYKStryker Announces Definitive Agreement to Acquire Assets of Small Bone Innovations, Inc.
Kalamazoo, Michigan - June 30, 2014 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire assets of Small Bone Innovations, Inc. ("SBi") in an all cash transaction for up to $375 million. The net cost to Stryker after taking into account the present v
Read more →SYKStryker to Host Conference Call on July 17, 2014
Kalamazoo, Michigan - June 12, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 17, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2014 and provide an operational upda
Read more →SYKStryker to Present at Investor Conferences
Kalamazoo, Michigan - May 22, 2014 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: June 2, 2014 - 10:30 a.m. Eastern Time Jefferies 2014 Healthcare Conference June 10, 2014 - 8:40 a.m. Pacific Time Goldman Sachs
Read more →SYKStryker Corporation Announces Pricing of $1.0 Billion Senior Notes Offering
Kalamazoo, Michigan - April 28, 2014 - Stryker Corporation (NYSE:SYK) (the "Company") announced today that it has priced an offering to sell $600 million of senior unsecured notes due 2024 (the "2024 Notes") and $400 million of senior unsecured notes due 2044 (the "2044 Notes" an
Read more →SYKStryker Reports First Quarter 2014 Results and 2014 Outlook
Kalamazoo, Michigan - April 23, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2014: First Quarter Highlights Net sales growth of 5.3% to $2.3 billion · Reconstructive 4.5% or 5.9% constant curren
Read more →SYKStryker Completes Acquisition of Berchtold Holding AG
Kalamazoo, Michigan - April 15, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Berchtold Holding AG (Berchtold), a provider of customer-centric healthcare equipment for over 90 years. Berchtold's product portfolio
Read more →SYKStryker Announces Legal Function Leadership Change
Kalamazoo, Michigan - March 31, 2014 - Stryker Corporation (NYSE:SYK) announced that Curtis E. Hall, Vice President and Chief Legal Officer, has elected to shift to a part-time role as Senior Legal Counsel, and transition the leadership of the Corporation's Legal and Compliance f
Read more →SYKStryker to Host Conference Call on April 23, 2014
Kalamazoo, Michigan - March 24, 2014 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, April 23, 2014 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2014 and provide an operational
Read more →SYKStryker Completes Acquisition of Patient Safety Technologies, Inc.
Kalamazoo, Michigan - March 24, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Patient Safety Technologies, Inc. Patient Safety conducts its business through its wholly owned subsidiary, SurgiCount Medical, Inc. Pa
Read more →SYKStryker Completes Acquisition of Pivot Medical, Inc.
Kalamazoo, Michigan - March 7, 2014 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of Pivot Medical, Inc. (Pivot). Pivot is a privately held business selling innovative products for hip arthroscopy with operating facilities
Read more →SYKStryker Announces Definitive Agreement to Acquire Pivot Medical, Inc.
Kalamazoo, Michigan - February 19, 2014 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Pivot Medical, Inc. (Pivot) in an all cash transaction. Pivot is a privately held business selling innovative products for hip arthroscopy with operating fac
Read more →SYKStryker Declares a 15% Increase in Quarterly Dividend
Kalamazoo, Michigan - February 12, 2014 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has increased its dividend 15%, compared to the prior year, by declaring a quarterly dividend of $0.305 per share payable on April 30, 2014, to shareholders of record at
Read more →SYKStryker Reports Fourth Quarter and Full Year 2013 Results and 2014 Outlook
Kalamazoo, Michigan - January 22, 2014 - Stryker Corporation (NYSE:SYK) reported operating results for the fourth quarter and full year 2013: Fourth Quarter Highlights Net sales growth of 5.6% to $2.5 billion Reconstructive 5.8% or 8.0% constant curren
Read more →SYKStryker Corporation Named One of Fortune Magazine's "100 Best Companies to Work For"
Fourth consecutive year Stryker has been named to this list Ranked 42 out of 100 Kalamazoo, Michigan - January 16, 2014 - Stryker Corporation (NYSE:SYK) announced today that it has been named as one of the 2014 FORTUNE 100 Best Companies to Work For® in its 17th annual survey o
Read more →SYKStryker Announces Definitive Agreement to Acquire Patient Safety Technologies, Inc. for $120 Million
Kalamazoo, Michigan - December 31, 2013 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire Patient Safety Technologies, Inc. (PSTX) for $2.22 per share, with an aggregate purchase price of $120 million. Patient Safety Technologies conducts its busi
Read more →SYKStryker Receives FDA Clearance for Waste Management System
Kalamazoo, Michigan - December 30, 2013 - Stryker Corporation (NYSE: SYK) announced today that its Instruments division has received 510(k) clearance for the Neptune 2 Waste Management System from the U.S. Food and Drug Administration (FDA). The Neptune 2 Waste Management System
Read more →SYKStryker Completes Acquisition of MAKO Surgical Corp.
Kalamazoo, Michigan - December 17, 2013 - Stryker Corporation (NYSE:SYK) announced today the completion of its previously announced acquisition of MAKO Surgical Corp., a pioneer in the advancement of robotic arm assisted surgery in orthopaedics. "We're excited to welcome MAKO in
Read more →SYKStryker to Provide Fourth Quarter 2013 Results and 2014 Outlook on January 22, 2014
Kalamazoo, Michigan - December 13, 2013 - Stryker Corporation (NYSE:SYK) announced that it will release operating results for the quarter ended December 31, 2013 on Wednesday, January 22, 2014, at 4:00 p.m., Eastern Time. The Company will host a conference call at 4:30 p.m., East
Read more →SYKStryker R&D Executive to Speak at Clinical Research Conference on December 4, 2013
ATLANTA, GA--(Marketwired - Nov 26, 2013) - Marc Long, PhD, Senior Director, Technology and Innovation, Stryker Orthobiologics, will provide a keynote address at the second annual Clinical Research in Georgia Conference. The Conference will be held on December 4th, 2013, at the A
Read more →SYKStryker Announces Election of New Director, Andrew K. Silvernail
Kalamazoo, Michigan - November 26, 2013 - Stryker Corporation (NYSE:SYK) Stryker Corporation (NYSE:SYK) announced the addition of a new member to its Board of Directors with the election of Andrew K. Silvernail as a director, effective November 26, 2013. Mr. Silvernail is Chairm
Read more →SYKStryker Reports Third Quarter 2013 Results
Kalamazoo, Michigan - October 17, 2013 - Stryker Corporation (NYSE:SYK) reported operating results for the third quarter of 2013: Third Quarter Highlights Net sales growth of 4.8% to $2.2 billion Reconstructive increased 6.5% as reported, 9.2% constant currency MedSurg increa
Read more →SYKStryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
Kalamazoo, Michigan - September 25, 2013 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire MAKO Surgical Corp. (MAKO) for $30.00 per share with an aggregate purchase price of approximately $1.65 billion. This transaction contemplates the issuance
Read more →SYKStryker to Host Conference Call on October 17, 2013
Kalamazoo, Michigan - September 17, 2013 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, October 17, 2013 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2013 and provide an ope
Read more →SYKStryker Declares a $0.265 Per Share Quarterly Dividend
Kalamazoo, Michigan - July 25, 2013 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.265 per share payable on October 31, 2013, to shareholders of record at the close of business on September 30, 2013, representing an
Read more →SYKStryker Reports Second Quarter 2013 Results
Kalamazoo, Michigan - July 18, 2013 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2013: Second Quarter Highlights Net sales growth of 5.0% to $2.2 billion Reconstructive increased 5.6% as reported, 7.6% constant currency MedSurg increas
Read more →SYKStryker to Host Conference Call on July 18, 2013
Kalamazoo, Michigan - June 18, 2013 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Thursday, July 18, 2013 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2013 and provide an operational upda
Read more →SYKStryker Extends Co-Marketing Agreement With OrthoSensor(TM) Inc.
MAHWAH, NJ and SUNRISE, FL--(Marketwired - May 22, 2013) - Stryker Corporation's Orthopaedics division and OrthoSensor , Inc., the leader in intelligent orthopedics, today announced an extension of their co-marketing agreement for Stryker's Triathlon Knee System and OrthoSensor's
Read more →SYKStryker Reports First Quarter 2013 Results
Kalamazoo, Michigan - April 24, 2013 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2013: First Quarter Highlights Net sales growth of 1.3% to $2.2 billion Reconstructive increased 1.2% as reported, 2.8% constant currency MedSurg increase
Read more →SYKStryker Announces Appointment of William Jellison to the Position of Vice President, Chief Financial Officer
Kalamazoo, Michigan - April 8, 2013 - Stryker Corporation (NYSE:SYK) announced that William Jellison has joined the Company in the position of Vice President, Chief Financial Officer reporting to Kevin A. Lobo, President and Chief Executive Officer, effective April 22, 2013. In
Read more →SYKStryker to Host Conference Call on April 24, 2013
Kalamazoo, Michigan - March 27, 2013 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, April 24, 2013 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2013 and provide an operational
Read more →SYKStryker Hip Replacement Recall News: Rottenstein Law Group Responds to Reports That FDA Issued Warning to Metal-on-Metal Hip Maker
NEW YORK, March 12, 2013 (GLOBE NEWSWIRE) -- Metal-on-metal hip implant maker Stryker announced* this week that it received a warning from the U.S. Food and Drug Administration related to concerns about quality at its Portage, Mich., factory. The Rottenstein Law Group, which repr
Read more →SYKStryker Receives FDA Warning Letter
Kalamazoo, Michigan - March 12, 2013 - Stryker Corporation (NYSE: SYK) announced today that its Instruments division has received a warning letter from the U.S. Food and Drug Administration (FDA) related to observations made during a November 2012 inspection at its Portage, Michi
Read more →SYKStryker Announces $250 Million Accelerated Share Repurchase Program
Kalamazoo, Michigan - March 1, 2013 - Stryker Corporation (NYSE:SYK) announced today it has entered into an Accelerated Share Repurchase agreement (ASR) with JPMorgan Chase Bank, NA to repurchase an aggregate of $250 million of the Company's common stock. The ASR is part of the
Read more →SYKStryker Completes Acquisition of Trauson Holdings Company Limited
Kalamazoo, Michigan - March 1, 2013 - Stryker Corporation (NYSE:SYK) announced today the successful completion of its previously announced voluntary general offer to acquire Trauson Holdings Company Limited (Trauson). Trauson is the leading trauma manufacturer in China and a majo
Read more →SYKStryker Announces Correction of Dividend Record Date
Kalamazoo, Michigan - February 14, 2013 - Stryker Corporation (NYSE:SYK) announced today that the record date for its quarterly dividend of $0.265 per share payable on April 30, 2013, will be March 28, 2013, instead of the previously announced record date of March 29, 2013. Stry
Read more →SYKStryker Declares a $0.265 per Share Quarterly Dividend
Kalamazoo, Michigan - February 13, 2013 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.265 per share payable on April 30, 2013, to shareholders of record at the close of business on March 29, 2013, representing an in
Read more →SYKStryker Reports Fourth Quarter and Full Year 2012 Results
Kalamazoo, Michigan - January 23, 2013 - Stryker Corporation (NYSE:SYK) reported operating results for the fourth quarter and full year 2012: Net sales growth of 5.5% to $2.3 billion Reconstructive increased 6.7% as reported, 7.4% constant currency MedSurg increased 2.4% as re
Read more →SYKStryker Announces Definitive Offer to Acquire Trauson Holdings Company Limited
Kalamazoo, Michigan - January 17, 2013 - Stryker Corporation (NYSE:SYK) and Trauson Holdings Company Limited (SEHK:0325.HK) announced today that Stryker will make a voluntary general offer to acquire all the shares of Trauson for HK$7.50 per ordinary share for a total considerati
Read more →SYKStryker Provides Preliminary 2012 Results and Updates 2013 Outlook
Preliminary Fourth Quarter Highlights Preliminary net sales growth of 5.5% to $2.3 billion Reconstructive increased 6.7% as reported, 7.4% constant currency MedSurg increased 2.4% as reported, 2.7% constant currency Neurotechnology and Spine increased 9.7% as reported, 10.8%
Read more →SYKStryker Announces Appointment of Scott Bruder, MD, PhD to the Position of Vice President, Chief Medical and Scientific Officer
Kalamazoo, Michigan - (January 7, 2013) - Stryker Corporation (NYSE:SYK) announced that Scott P. Bruder, MD, PhD has joined the Company in the newly created position of Vice President, Chief Medical and Scientific Officer, reporting to Kevin A. Lobo, President and Chief Executive
Read more →SYKStryker Declares a 25% Increase in Quarterly Dividend and Announces Increase in Its Share Repurchase Authorization to $1 Billion
Kalamazoo, Michigan - December 5, 2012 - Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has increased its dividend 25% by declaring a quarterly dividend of $0.265 per share payable on January 31, 2013, to shareholders of record at the close of business
Read more →SYKStryker Announces Changes to Executive Leadership
Kalamazoo, Michigan - November 8, 2012 - Stryker Corporation (NYSE:SYK) announced today the appointment of David K. Floyd to the role of Group President, Orthopaedics, effective November 15, 2012. Orthopaedics includes the Company's Reconstructive, Trauma and Extremities, Joint P
Read more →SYKStryker Completes Acquisition of Privately-Held Surpass Medical, Ltd.
Kalamazoo, Michigan - November 1, 2012 - Stryker Corporation (NYSE:SYK) announced today the closing of its previously announced acquisition of privately-held Surpass Medical, Ltd. (Surpass). Surpass is developing and commercializing the NeuroEndoGraft family of next-generation fl
Read more →SYKStryker Reports Third Quarter 2012 Results
Sales of $2.1 billion, growth of 1.0% Adjusted diluted net earnings per share(1) of $0.97, growth of 6.6% Adjusted diluted net earnings per share full year guidance revised to a range of $4.04 to $4.07 per share for 2012 and $4.25 to $4.40 for 2013 Kalamazoo, Michigan - Octobe
Read more →SYKStryker Announces Definitive Agreement to Acquire Privately-Held Surpass Medical, Ltd. for $135 Million
Kalamazoo, Michigan - October 16, 2012 - Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire privately-held Surpass Medical, Ltd. (Surpass) in an all cash transaction for $100 million and up to an additional $35 million of milestone payments. Founded
Read more →SYKStryker Names Kevin A. Lobo as President and Chief Executive Officer
Kalamazoo, Michigan - October 1, 2012 - Stryker Corporation's (NYSE:SYK) Board of Directors announced today that Kevin A. Lobo has been named the Company's President and Chief Executive Officer, effective immediately. He has also been named to the Company's Board of Directors. Mr
Read more →SYKStryker to Host Conference Call on October 17, 2012
Kalamazoo, Michigan - September 18, 2012 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, October 17, 2012 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2012, and provide an o
Read more →SYKStryker Declares a $0.2125 per Share Quarterly Dividend
Kalamazoo, Michigan - September 10, 2012 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.2125 per share payable on October 31, 2012, to shareholders of record at the close of business on September 28, 2012, representi
Read more →SYKSTRYKER TO PRESENT AT INVESTOR CONFERENCES
Kalamazoo, Michigan - September 5, 2012 - Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: September 11, 2012 - 9:10 a.m. Eastern Time Morgan Stanley Global Healthcare Conference September 13, 2012 - 6:20 a.m. Easte
Read more →SYKStryker Reports Second Quarter 2012 Results
Sales of $2.1 billion, growth of 2.9% Adjusted diluted net earnings per share(1) of $0.98, growth of 8.9% Kalamazoo, Michigan - July 18, 2012 - Stryker Corporation (NYSE:SYK) reported operating results for the second quarter of 2012 with net sales of $2.1 billion, up 2.9% and a
Read more →SYKStryker to Host Conference Call on July 18, 2012
Kalamazoo, Michigan - June 7, 2012 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Wednesday, July 18, 2012 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2012, and provide an operational upd
Read more →SYKStryker Reports First Quarter 2012 Results
Net sales growth of 7.2% to $2.2 billion Adjusted diluted net earnings per share(1) growth of 10.0% to $0.99 Kalamazoo, Michigan - April 17, 2012 - Stryker Corporation (NYSE:SYK) reported operating results for the first quarter of 2012: Reported net sales increased 7.2% to $2.
Read more →SYKStryker to Host Conference Call on April 17, 2012
Kalamazoo, Michigan - March 12, 2012 - Stryker Corporation (NYSE:SYK) announced that it will host a conference call on Tuesday, April 17, 2012 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2012, and provide an operational u
Read more →SYKStryker Declares a $0.2125 Per Share Quarterly Dividend
Kalamazoo, Michigan - February 9, 2012 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.2125 per share payable on April 30, 2012, to shareholders of record at the close of business on March 30, 2012. With an 18% incre
Read more →SYKStryker Reports Fourth Quarter and Full Year 2011 Results
Fourth Quarter Highlights Net sales growth of 11.0% to $2.2 billion Adjusted diluted net earnings per share(1) growth of 9.7% to $1.02 Cash from operations growth of 21% to $627 million Kalamazoo, Michigan - January 24, 2012 - Stryker Corporation (NYSE:SYK) reported operating
Read more →SYKStryker Reaches Settlement with the U.S. Attorney's Office
Kalamazoo, Michigan - January 18, 2012 - Stryker Corporation (NYSE:SYK) announced today that Stryker Biotech has reached a settlement with the U.S. Attorney's Office for the District of Massachusetts. As part of the settlement, Stryker has agreed to plead to one misdemeanor char
Read more →SYKStryker Increases Expected 2011 Results and Provides 2012 Outlook
Kalamazoo, Michigan - January 10, 2012 - Stryker Corporation (NYSE:SYK) announced today that preliminary net sales were $2.2 billion for the fourth quarter of 2011, representing an 11.0% increase over net sales of $2.0 billion for the fourth quarter of 2010. On a constant currenc
Read more →SYKStryker Announces Additional $500 Million Share Repurchase Program and Declares 18% Increase in Quarterly Dividend
Kalamazoo, Michigan - December 7, 2011 - Stryker Corporation (NYSE:SYK) announced today that its Board of Directors has increased its dividend 18% by declaring a quarterly dividend of $0.2125 per share payable on January 31, 2012, to shareholders of record at the close of busines
Read more →Competitive Position
How SYK ranks across every disease it competes inCompetitive Position is a premium feature
See how SYK ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial